Hydrogels as advanced therapeutic delivery systems for improved cancer immunotherapy: current progress, challenges, and future prospects.
Immunotherapy has emerged as a new clinical paradigm for cancer management, leveraging immunomodulation to enhance systemic antitumor responses. Despite its significant potency and distinct advantages, challenges such as limited patient response rates and immune-related toxicities persist. Although nanomaterial-based d...